uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Troponin-Specific Autoantibody Interference in Different Cardiac Troponin I Assay Configurations
Show others and affiliations
2012 (English)In: Clinical Chemistry, ISSN 0009-9147, E-ISSN 1530-8561, Vol. 58, no 6, 1040-1048 p.Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Autoantibodies to cardiac troponins (cTnAAb) can interfere with the measurement of cardiac troponin I (cTnI) by immunoassays. The aim of this study was to explore the degree of cTnAAb interference in different cTnI assay configurations. METHODS: Ternary troponin complex was added into samples (serum or plasma, n = 132, 68% cTnAAb positive) from individuals without known cardiac conditions. The recovery of cTnI was then measured with 6 investigational cTnI assays (2, 3, or 4 antibodies per assay). Three of these assays were then selected for further comparison by use of samples (plasma, n = 210, 33% cTnAAb positive) from non-ST-elevation acute coronary syndrome patients in the FRISC-II (FRagmin/Fast Revascularisation during InStability in Coronary artery disease) cohort. Finally, these results were compared to those obtained with 3 commercial cTnI assays. RESULTS: Analytical recoveries varied widely among the 6 investigational assays. Notably the low recoveries (median 9%) of the midfragment-targeting reference assay were normalized (median 103%) with the use of the 4-antibody assay construct (3 capture, 1 tracer antibody) with only 1 antibody against a midfragment epitope. Reduced analytical recoveries correlated closely with measured autoantibody amounts. cTnI concentrations from cTnAAb-positive patient samples determined with 3 investigational assays confirmed the reduced concentrations expected from the low analytical recoveries. The results from the commercial cTnI assays with antibody selections representative for contemporary assay constructs revealed a similar underestimation (up to 20-fold) of cTnI in cTnAAb-positive samples. CONCLUSIONS: A novel cTnI assay deviating from the conventional IFCC-recommended midfragment approach substantially improves cTnI detection in samples containing cTnAAbs.

Place, publisher, year, edition, pages
2012. Vol. 58, no 6, 1040-1048 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-177229DOI: 10.1373/clinchem.2011.179226ISI: 000304842900015OAI: oai:DiVA.org:uu-177229DiVA: diva2:540306
Available from: 2012-07-09 Created: 2012-07-04 Last updated: 2013-01-08Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Lindahl, BertilEggers, Kai M.Venge, Per
By organisation
UCR-Uppsala Clinical Research CenterBiochemial structure and function
In the same journal
Clinical Chemistry
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 191 hits
ReferencesLink to record
Permanent link

Direct link